Cite
HARVARD Citation
Hargrave, D. et al. (n.d.). 407TiPPhase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600–mutant high-grade glioma (HGG) or low-grade glioma (LGG). Annals of oncology. p. . [Online].